Benefits

• Leverage therapy area insights
  Assess the current and future market size for biosimilars across six leading therapy areas: oncology, immunology, endocrinology, nephrology, respiratory, and ophthalmology.
• Keep track of emerging biosimilars
  Evaluate the global biosimilars pipeline and launch timing in major markets.
• Optimize your market access strategy
  Track how payers and physicians respond to launches of biosimilars and understand the factors that will drive or limit use.
• Inform strategic decision-making
  Use actionable recommendations based on strategies used by both reference brand and biosimilar developers to defend and maximize their market share.

• Coverage of the biosimilars market since 2006
• Market sizing for over 30 reference brand biologics
• 10-year interactive forecast covering the U.S., Europe and Japan
• Annual surveys of over 500 physicians across six key specialties and in-depth interviews with payers from the U.S. and E.U.